Many implied that their compounded products were equivalent to, or interchangeable with, FDA-approved branded medications (for example, suggesting that compounded GLP-1 drugs contained the same ingredients as branded products or had been tested in clinical trials)
Chondrocyte ferroptosis in cartilage degeneration in OA Ferroptosis in chondrocytes plays an important role in OA progression and provides potential insights into its treatment
doi: 10.1126/science.1070477 56 MakkerJ.ChilimuriS.BellaJ
References Product warnings updated for GLP-1 RA class, 01 December 2025, Therapeutic Good Administrations, GLP-1 RAs: warnings aligned over potential risk of suicidal thoughts or behaviours, 01 December 2025, Therapeutic Good Administration, Updated contraception advice for Mounjaro (tirzepatide), 01 December 2025, Therapeutic Good Administrations, GLP-1 medicines for weight loss and diabetes: what you need to know, 20 August 2025, Medicine and Healthcare Product Regulatory Agency, Australias drug regulator issues mental health warning for weight-loss drugs including Ozempic, 01 December 2025,